SE465428B - Naftoxaziner, deras framstaellning och anvaendning - Google Patents

Naftoxaziner, deras framstaellning och anvaendning

Info

Publication number
SE465428B
SE465428B SE8502865A SE8502865A SE465428B SE 465428 B SE465428 B SE 465428B SE 8502865 A SE8502865 A SE 8502865A SE 8502865 A SE8502865 A SE 8502865A SE 465428 B SE465428 B SE 465428B
Authority
SE
Sweden
Prior art keywords
carbon atoms
formula
compounds
acid addition
alkylthio
Prior art date
Application number
SE8502865A
Other languages
English (en)
Swedish (sv)
Other versions
SE8502865D0 (sv
SE8502865L (sv
Inventor
J Nozulak
R K A Giger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8502865D0 publication Critical patent/SE8502865D0/xx
Publication of SE8502865L publication Critical patent/SE8502865L/xx
Publication of SE465428B publication Critical patent/SE465428B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8502865A 1984-06-12 1985-06-10 Naftoxaziner, deras framstaellning och anvaendning SE465428B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3421729 1984-06-12
DE3508263 1985-03-08

Publications (3)

Publication Number Publication Date
SE8502865D0 SE8502865D0 (sv) 1985-06-10
SE8502865L SE8502865L (sv) 1985-12-13
SE465428B true SE465428B (sv) 1991-09-09

Family

ID=25822036

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8502865A SE465428B (sv) 1984-06-12 1985-06-10 Naftoxaziner, deras framstaellning och anvaendning

Country Status (28)

Country Link
US (1) US4656167A (nl)
JP (1) JPS611676A (nl)
AT (1) AT394717B (nl)
AU (1) AU582751B2 (nl)
BE (1) BE902600A (nl)
CA (1) CA1285561C (nl)
CH (1) CH666031A5 (nl)
CY (1) CY1581A (nl)
DE (1) DE3520104C2 (nl)
DK (1) DK172306B1 (nl)
ES (1) ES8704469A1 (nl)
FI (1) FI86301C (nl)
FR (1) FR2565586B1 (nl)
GB (1) GB2160200B (nl)
GR (1) GR851418B (nl)
HK (1) HK11891A (nl)
HU (1) HU193979B (nl)
IE (1) IE58398B1 (nl)
IL (1) IL75468A (nl)
IT (1) IT1200079B (nl)
LU (1) LU85941A1 (nl)
MY (1) MY102059A (nl)
NL (1) NL194166C (nl)
NZ (1) NZ212358A (nl)
PH (1) PH23666A (nl)
PT (1) PT80634B (nl)
SE (1) SE465428B (nl)
SG (1) SG9691G (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
HU214591B (hu) * 1989-12-14 1998-04-28 Novartis Ag. Eljárás egy naftoxazinszármazék malonátsójának és az ilyen hatóanyagot tartalmazó gyógyszerkészítmények előállítására
DE4329776A1 (de) * 1993-09-03 1995-03-09 Sandoz Ag Naphthoxazine, ihre Herstellung und Verwendung
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
JP2011525893A (ja) * 2008-06-27 2011-09-29 ハー・ルンドベック・アクチエゼルスカベット 新規のフェノールアミン類およびカテコールアミン類ならびにそのプロドラッグ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2194421B1 (nl) * 1972-08-03 1975-10-17 Cerpha
AU521527B2 (en) * 1979-09-12 1982-04-08 Dow Chemical Company, The Dehydrohalogenation of (polyhaloalkyl) benzenes
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
DE4003262A1 (de) * 1990-02-03 1991-08-08 Sandoz Ag Neues naphthoxazin, seine herstellung und verwendung

Also Published As

Publication number Publication date
GB2160200A (en) 1985-12-18
IL75468A (en) 1989-05-15
HUT39438A (en) 1986-09-29
LU85941A1 (fr) 1986-01-24
FI852325L (fi) 1985-12-13
GB2160200B (en) 1988-03-16
SE8502865D0 (sv) 1985-06-10
CY1581A (en) 1992-04-03
NZ212358A (en) 1989-01-27
DE3520104A1 (de) 1985-12-12
FI852325A0 (fi) 1985-06-11
FI86301C (fi) 1992-08-10
FR2565586B1 (fr) 1989-09-15
ATA172385A (de) 1991-11-15
JPS611676A (ja) 1986-01-07
DE3520104C2 (de) 1997-01-23
IL75468A0 (en) 1985-10-31
HU193979B (en) 1987-12-28
IE58398B1 (en) 1993-09-08
FR2565586A1 (fr) 1985-12-13
IT8548195A0 (it) 1985-06-11
NL8501526A (nl) 1986-01-02
AT394717B (de) 1992-06-10
AU582751B2 (en) 1989-04-13
PT80634B (pt) 1987-10-20
DK259185D0 (da) 1985-06-10
IE851437L (en) 1985-12-12
FI86301B (fi) 1992-04-30
PH23666A (en) 1989-09-27
CA1285561C (en) 1991-07-02
ES8704469A1 (es) 1987-04-01
SG9691G (en) 1991-04-05
NL194166C (nl) 2001-08-03
PT80634A (en) 1985-07-01
NL194166B (nl) 2001-04-02
DK259185A (da) 1985-12-13
GR851418B (nl) 1985-11-25
SE8502865L (sv) 1985-12-13
BE902600A (fr) 1985-12-06
CH666031A5 (de) 1988-06-30
DK172306B1 (da) 1998-03-09
AU4345885A (en) 1985-12-19
ES544074A0 (es) 1987-04-01
US4656167A (en) 1987-04-07
JPH0576472B2 (nl) 1993-10-22
IT1200079B (it) 1989-01-05
HK11891A (en) 1991-02-22
MY102059A (en) 1992-03-31
GB8514636D0 (en) 1985-07-10

Similar Documents

Publication Publication Date Title
FI90241B (fi) Menetelmä terapeuttisesti aktiivisen S(-)-9-halogeeni-3-alkyyli-10-(4-alkyylipiperatsinyyli)-7-okso-2,3-dihydro-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihapon valmistamiseksi
HUT77129A (hu) 2,3,4,5-Tetrahidro-1,4-benzotiazepin-1,1-dioxid-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
PT1260512E (pt) ''novos derivados de amida cíclicos''
EP1490361B1 (en) Polycyclic compounds as potent alpha2-adrenoceptor antagonists
SE465428B (sv) Naftoxaziner, deras framstaellning och anvaendning
DK167020B1 (da) Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner
EP3747863A1 (en) Probucol derivative, preparation method therefor and use thereof
JP2021504298A (ja) 芳香族化合物、薬学的組成物及びその使用
PT97944B (pt) Processo para a preparacao de derivados de hexa-hidroazepina
JPS62252790A (ja) ピリドベンゾオキサジン誘導体
US8063037B2 (en) Progesterone receptor modulators
AU2009242219B2 (en) Benzocycloheptane and benzoxepine derivatives
CN112996566B (zh) 用于治疗和预防乙型肝炎病毒感染的苯并二氢吡喃-4-酮衍生物
KR950009862B1 (ko) 벤조피란 유도체와 그의 제조방법(1)
SK158095A3 (en) Application of 1,2-bridged 1,4-dihydropyridines, 1,2-bridged 1,4-dihydropyridines, manufacturing process thereof and pharmaceutical compositions containing them
CZ239496A3 (en) Substituted 4h-pyrans, process of their preparation, their use and pharmaceutical composition containing thereof
SAIGA et al. Synthesis of 1, 2, 3, 4-Tetrahydro-β-carboline Derivatives as Hepatoprotective Agents. II. Alkyl 1, 2, 3, 4-Tetrahydro-β-carboline-2-carbodithioates
WO2022215754A1 (ja) 二環性ピリジン誘導体
AU659250B2 (en) 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoxaline derivatives, processes for producing the same and use as a pharmaceutical
EP2155757B1 (en) New progesterone receptor modulators
KR900008398B1 (ko) 나프트 옥사진의 제조방법
PL150777B1 (pl) Sposób wytwarzania naftooksazyn
AU2022275207A1 (en) Rescorcinols, methods for their manufacture, and uses thereof
CN117769545A (zh) 含三并环类衍生物调节剂、其制备方法和应用
DK175312B1 (da) Optisk aktive benzoxazinderivater

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8502865-2

Format of ref document f/p: F

NUG Patent has lapsed